Nurses need to know how to assess a patient’s risk of TLS and the treatment goals for successful management.
The integration of billing procedures into medical records introduces the need for nurses to understand billing systems and medical payors.
The issue of cancer care disparity is complex, as it is both a medical and a socioeconomic issue. Socioeconomic factors are the most universal contributors.
The role of B cells in GVHD is prompting research on the effectiveness of rituximab for this common adverse effect of allogeneic hematopoietic stem cell transplantation.
Signs and symptoms of venous thromboembolism in oncology patients should be heeded with prompt therapeutic and mechanical interventions.
The main types of leukemia that affect most patients with the disease are classified by four characteristics: acute vs chronic and myeloid vs lymphoid. Each type of leukemia and its treatment has unique symptoms and risks. Oncology nurses should be able to distinguish these symptoms and educate patients appropriately.
Based on data regarding the risks associated with erythropoietinstimulating agents (ESAs), the FDA recommended a Risk Evaluation Mitigation Strategy (REMS) program for these agents. Nurses play an important role in ensuring that prescribed treatment plans are appropriate for a particular patient (eg, laboratory parameters are appropriate).
The most common complications associated with VADs are catheter-related infections and occlusions. Diagnosis and management of these complications, however, are not standardized and remain a challenge to nurses.
From the September/October 2011 Oncology Nurse Advisor: This activity is designed to give an overview of the causes of CIPN, its symptoms, and possible prevention and treatment strategies.
From the July/August 2011 Oncology Nurse Advisor: Knowledge of the risk factors for ototoxicity and understanding the appropriate interventions can help promote continued social and emotional development in young patients.
From the May/June 2011 Oncology Nurse Advisor: Management and prognosis for patients with non-Hodgkin lymphoma depend on identifying the disease type. This review discusses the diagnoses and optimal treatments.
From the March/April 2011 Oncology Nurse Advisor:Hereditary nonpolyposis colorectal cancer is caused by an inherited genetic mutation. This review explains how to screen and counsel patients at risk.
From the January/February 2011 Oncology Nurse Advisor:Successful management of cancer-related fatigue can influence whether a patient continues with therapy. Fatigue is one of the most common complaints of patients with cancer.
From the November/December 2010 Oncology Nurse Advisor:Even though a number of new antiemetic drugs have become available in the past two decades, chemotherapy-induced nausea and vomiting (CINV) remains among the top three complaints of patients undergoing chemotherapy. Excellent progress has been made in the prevention of acute-onset CINV, but delayed ...
From the September/October 2010 Oncology Nurse Advisor: Understanding and being able to recognize the symptoms of CF/STS and knowing how to manage and prevent the negative consequences can be critical to the personal and professional health of the nurse.
From the August 2010 Oncology Nurse Advisor:Treatment of lung cancer has shown promising improvements in the past 5 years. The class of drugs known as epidermal growth factor receptor (EGFR) inhibitors has increased response rates and overall survival.
From the July 2010 Oncology Nurse Advisor: Hand-foot syndromes and hand-foot skin reactions are becoming even more prevalent with the increasing use of novel targeted agents such as tyrosine kinase inhibitors. Because treatments are mainly anecdotal, prevention, early recognition, and aggressive intervention are necessary to manage these syndromes effectively and ...
If clinical trials are a part of an oncology nurse's practice, she will be expected to assist with paperwork, data recording, and explaining the study to prospective participants. It is important that nurses understand the basics of cancer research in general and each study being done in particular to better ...